• 1
    Kearney PM, Whelton M, Reynolds K, et al. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217223.
  • 2
    Whelton PK, He J, Muntner P. Prevalence, awareness, treatment and control of hypertension in North America, North Africa and Asia. J Hum Hypertens. 2004;18(8):545551.
  • 3
    Opie LH, Seedat YK. Hypertension in sub-Saharan African populations. Circulation. 2005;112:35623568.
  • 4
    Lawes CMM, Vander Hoorn S, Law MR, et al. Blood pressure and the global burden of disease 2000. Part I: estimates of blood pressure levels. J Hypertens. 2006;24(3):413422.
  • 5
    Vasan RS, Beiser A, Seshadri S, et al. Residual lifetime risk for developing hypertension in middle-aged women and men. JAMA. 2002;287(8):10031010.
  • 6
    World Health Organization. The World Health Report 2002. Geneva, Switzerland: World Health Organization; 2002.
  • 7
    Gueyffier F, Froment A, Gouton M. New meta-analysis of treatment trials of hypertension: improving the estimate of therapeutic benefit. J Hum Hypertens. 1996;10(1):18.
  • 8
    Smith SC Jr, Blair SN, Criqui MH, et al. Preventing heart attack and death in patients with coronary disease. Circulation. 1995; 92(1):24.
  • 9
    Wolf-Maier K, Cooper RS, Banegas JR, et al. Hypertension Prevalence and Blood Pressure Levels in 6 European Countries, Canada, and the United States. JAMA. 2003;289(18):23632369.
  • 10
    Kearney PM, Whelton M, Reynolds K, et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22(1):1119.
  • 11
    Petrella RJ, Campbell NRC. Awareness and misconception of hypertension in Canada: results of a national survey. Can J Cardiol. 2005;21(7):589593.
  • 12
    Joffres MR, Ghadirian P, Fodor JG, et al. Awareness, treatment, and control of hypertension in Canada. Am J Hypertens. 1997;10(10, pt 1):10971102.
  • 13
    Schmeiser-Rieder A, Kunze U. Blood pressure awareness in Austria. A 20 year evaluation, 1978–1998. Eur Heart J. 2000;21(5):414420.
  • 14
    Altun B, Arici M, Nergizoglu G, et al. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens. 2005;23(10):18171823.
  • 15
    Stergiou GS, Thomopoulou GC, Skeva II, et al. Prevalence, Awareness, Treatment, and Control of Hypertension in Greece. The Didima Study. Am J Hypertens. 1999;12(10, pt 1):959965.
  • 16
    Al-Roomi KA, Heller RF. Blood pressure measurement in an Australian population. Med J Aust. 1987;146(4):198200.
  • 17
    Pan WH, Chang HY, Yeh WT, et al. Prevalence, awareness, treatment and control of hypertension in Taiwan: results of Nutrition and Health Survey in Taiwan (NAHSIT) 1993–1996. J Hum Hypertens. 2001;15(11):793798.
  • 18
    Brownstein JN, Chowdhury FM, Norris SL, et al. Effectiveness of community health workers in the care of people with hypertension. Am J Prev Med. 2007;32(5):435447.
  • 19
    Brownstein JN, Bone LR, Dennison CR, et al. Community health workers as interventionists in the prevention and control of heart disease and stroke. Am J Prev Med. 2005;29(5 suppl 1):128133.
  • 20
    Giarratano G, Bustamante-Forest R, Carter C. A multicultural and multilingual outreach program for cervical and breast cancer screening. J Obstet Gynecol Neonatal Nurs. 2005;34(3):395402.
  • 21
    Chambers LW, Kaczorowski J, Levitt C, et al. Blood pressure self-monitoring in pharmacies. Building on existing resources. Can Fam Physician. 2002;48:15941595, 16021604.
  • 22
    Maxwell CJ, Bancej CM, Snider J. Predictors of the mammography use among Canadian women aged 50–69: findings from the 1996/97 National Population Health Survey. CMAJ. 2001;164(3):329334.
  • 23
    Quan H, Fong A, De Coster C, et al. Variation in health services utilization among ethnic populations. CMAJ. 2006;174(6):787791.
  • 24
    Lawrence DM. Chronic Disease Care: Rearranging the Deck Chairs. Ann Intern Med. 2005;143(6):458459.
  • 25
    Borenstein JE, Graber G, Saltiel E, et al. Physician-pharmacist comanagement of hypertension: a randomized, comparative trial. Pharmacotherapy. 2003;23(2):209216.
  • 26
    Lewanczuk R. Innovations in primary care: implications for hypertension detection and treatment. Can J Cardiol. 2006;22(7):614616.
  • 27
    Campbell NRC, McAlister FA, Brant R, et al. Temporal trends in antihypertensive drug prescriptions in Canada before and after introduction of the Canadian Hypertension Education Program. J Hypertens. 2003;21(8):15911597.
  • 28
    Campbell NRC, Tu K, Brant R, et al. The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends. Hypertension. 2006;47(1):2228.
  • 29
    Egan BM, Lackland DT, Cutler NE. Awareness, knowledge, and attitudes of older Americans about high blood pressure: implications for health care policy, education, and research. Arch Intern Med. 2003;163(6):681687.
  • 30
    Ragot S, Sosner P, Bouche G, et al. Appraisal of the knowledge of hypertensive patients and assessment of the role of the pharmacists in the management of hypertension: results of a regional survey. J Hum Hypertens. 2005;19(7):577584.
  • 31
    Simpson CF, Boyd CM, Carlson MC, et al. Agreement between self-report of disease diagnoses and medical record validation in disabled older women: factors that modify agreement. J Am Geriatr Soc. 2004;52:123127.
  • 32
    Kiss A. Does gender have an influence on the patient-physician communication? J Men Health Gender. 2004;1(1):7782.
  • 33
    Paasche-Orlow M, Roter D. The communication patterns of internal medicine and family practice physicians. J Am Board Fam Pract. 2003;16:485493.
  • 34
    Davidoff F. Time. Ann Intern Med. 1997;127:483485.
  • 35
    Moser M, Franklin SS. Hypertension management: result of a new national survey for the Hypertensive Education Foundation. Harris Interactive. J Clin Hypertens (Greenwich). 2007;9(5):316323.